Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Blend Labs (BLND) Common Equity (2020 - 2025)

Blend Labs has reported Common Equity over the past 6 years, most recently at -$30.5 million for Q4 2025.

  • Quarterly results put Common Equity at -$30.5 million for Q4 2025, up 45.93% from a year ago — trailing twelve months through Dec 2025 was -$30.5 million (up 45.93% YoY), and the annual figure for FY2025 was -$30.5 million, up 45.93%.
  • Common Equity for Q4 2025 was -$30.5 million at Blend Labs, down from -$13.4 million in the prior quarter.
  • Over the last five years, Common Equity for BLND hit a ceiling of $828.8 million in Q3 2021 and a floor of -$56.4 million in Q4 2024.
  • Median Common Equity over the past 5 years was $23.8 million (2023), compared with a mean of $184.3 million.
  • Biggest five-year swings in Common Equity: surged 406.5% in 2021 and later plummeted 888.33% in 2024.
  • Blend Labs' Common Equity stood at $774.6 million in 2021, then plummeted by 84.1% to $123.2 million in 2022, then tumbled by 115.62% to -$19.2 million in 2023, then tumbled by 192.86% to -$56.4 million in 2024, then surged by 45.93% to -$30.5 million in 2025.
  • The last three reported values for Common Equity were -$30.5 million (Q4 2025), -$13.4 million (Q3 2025), and -$23.1 million (Q2 2025) per Business Quant data.